
 JAMA Clinical Reviews
 JAMA Clinical Reviews Preexposure Prophylaxis (PrEP) Options for HIV
 Oct 14, 2024 
 Monica Gandhi, an infectious diseases specialist and professor at UCSF, dives into the world of preexposure prophylaxis (PrEP) for HIV. She discusses the alarming rate of new HIV infections globally and the innovative therapies available, including oral medications and the dapivirine ring, which empowers women in HIV prevention. Gandhi emphasizes the critical role of adherence in maximizing PrEP's effectiveness and shares strategies to improve it. She also advocates for primary care doctors to more widely prescribe PrEP, likening it to the adoption of contraception in healthcare. 
 Chapters 
 Transcript 
 Episode notes 
 1  2  3  4  5 
 Intro 
 00:00 • 2min 
 Exploring PrEP Therapies: Efficacy and Options for HIV Prevention 
 01:39 • 4min 
 Exploring the Dapivirine Ring: An Innovative HIV Prevention Method 
 05:18 • 2min 
 Strategies for Enhancing PrEP Adherence and On-Demand Options 
 07:36 • 3min 
 Enhancing PrEP Prescription in Primary Care 
 10:57 • 3min 
